# Lidocaine 5% Plasters (Versatis® 5%) in Pediatric Neuropathic Pains and Vasoocclusive Sickle Cell Crisis Pains

> **NCT01314300** · PHASE2 · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 39 (estimated)

## Conditions studied

- Neuropathic Pains
- Vasoocclusive Sickle Cell Crises Pains

## Interventions

- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT01314300
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2014-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01314300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01314300, "Lidocaine 5% Plasters (Versatis® 5%) in Pediatric Neuropathic Pains and Vasoocclusive Sickle Cell Crisis Pains". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01314300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*